Insomnia and Sleeping Medication Use on the Rise

Diagnoses of insomnia have been on the rise -- and so has the use of medication to treat this sleep disorder. The popularity of a newer class of drugs -- non-benzodiazepine sedative hypnotics -- has risen dramatically. Drugs included in this group include zolpidem, zaleplon, and eszopiclone, and are sometimes referred to as "Z-meds" or "Z-drugs." Some of the most frequently prescribed sleep medications contain these drugs, including Ambien and Ambien CR, Zolpimist, Intermezzo, Sonata and Lunesta.

There is a great deal we don't yet know about long-term risks and complications of these newer sleep medications. We are also just beginning to get a sense of how frequently they are being used by adults in the U.S. What's more, we know very little about the characteristics and non-sleep health and lifestyle factors that might influence a person's likelihood to use these medicines -- whether by their own prescription, or through sharing medication prescribed for someone else.

These are important questions to pursue. This information can help scientists achieve a deeper, more comprehensive understanding of the risks and effects of the drugs themselves and help clinicians treat insomnia and other sleep disorders safely and responsibly. A recently released study has addressed some of these gaps in knowledge. Researchers at Beth Israel Deaconess Hospital, Massachusetts General Hospital, and Harvard University conducted research to determine the prevalence of medications commonly prescribed for insomnia, and to examine the patterns of sleep medication use among adults in the U.S. They also investigated whether demographic, health, and lifestyle factors might be associated with a greater likelihood of use.

Researchers used data from the National Health and Nutrition Examination Survey (NHANES), an ongoing federal research project that collects and shares data about the health status and habits of children and adults in the U.S. The study used nationally-representative information from more than 32,000 men and women age 20 and older, collected between the years 1999 and 2010. The study identified people who had used medication commonly prescribed for insomnia within the past 30 days. Researchers also extracted details about the types of medication used, characteristics including age, gender, insurance status, and income, as well as health issues among those who'd used medication for sleep in the past month. Their analysis confirms a significant increase in the use of prescription sleep meds -- particularly "Z-meds "-- among American adults. Their results also paint a more detailed picture than we've seen before of the people who are more likely to rely on prescription medications for sleep, including women, older adults, and people who've sought mental health treatment:

• Between 1999 and 2010, rates of prescription sleep medication use rose significantly, from an estimated 2 percent of the population to 3.5 percent. That's more than 6 million adults in the U.S. who in 2010 reported using sleep medicines in the past month.
• The most commonly prescribed drugs were "Z-meds." Among these drugs, zolpidem was by far the most frequently used, comprising 87.5 percent of Z-med use.
• Rates of Z-med use increased by more than 3 times between 1999 and 2010.

Researchers found several characteristics associated with higher rates of use of prescription aids for sleep:

To continue reading this article visit http://www.huffingtonpost.com/dr-michael-j-breus/sleep-aids_b_4746587.html